{"celex_id": "31999R0508", "uri": "http://publications.europa.eu/resource/cellar/699d9aa5-b7e0-48cc-ac41-926b9a1e8b4b", "type": "Regulation", "concepts": ["1442", "2737", "343", "5734"], "title": "Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\n", "header": "COMMISSION REGULATION (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 2728/98 (2), and in particular Articles 6, 7 and 8 thereof,\nWhereas, since the adoption of Regulation (EEC) No 2377/90, the Annexes have been amended a number of times; whereas, since the texts are numerous, complex and dispersed among various Official Journals, they are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, certain of those Annexes should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected;\nWhereas the measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,", "main_body": ["Annexes I to IV to Regulation (EEC) No 2377/90 are hereby replaced by the texts set out in the Annex to this Regulation.", "This Regulation shall enter into force on the 60th day following that of its publication in the Official Journal of the European Communities.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 4 March 1999.\nFor the Commission\nMartin BANGEMANN\nMember of the Commission\n(1) OJ L 224, 18. 8. 1990, p. 1.\n(2) OJ L 343, 18. 12. 1998, p. 8.\nANNEX I\nLIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED\n1. Anti-infectious agents\n1.1. Chemotheurapeutics\n1.1.1. Sulfonamides\n>TABLE>\n1.1.2. Diamino pyrimidine derivatives\n>TABLE>\n1.2. Antibiotics\n1.2.1. Penicillins\n>TABLE>\n1.2.2. Cephalosporins\n>TABLE>\n1.2.3. Quinolones\n>TABLE>\n1.2.4. Macrolides\n>TABLE>\n1.2.5. Florfenicol and related compounds\n>TABLE>\n1.2.6. Tetracyclines\n>TABLE>\n1.2.7. Naphtalene-ringed ansamycin\n>TABLE>\n1.2.8. Pleuromutilines\n>TABLE>\n2. Antiparasitic agents\n2.1. Agents acting against endoparasites\n2.1.1. Salicylanilides\n>TABLE>\n2.1.2. Tatra-hydro-imidazoles (imidazolthiazoles)\n>TABLE>\n2.1.3. Benzimidazoles and pro-benzimidazoles\n>TABLE>\n2.2. Agents acting against ectoparasites\n2.2.1. Organophosphates\n>TABLE>\n2.2.2. Formamidines\n>TABLE>\n2.2.3. Pyrethroids\n>TABLE>\n2.3. Agents acting against endo- and ectoparasites\n2.3.1. Avermectins\n>TABLE>\n2.4. Agents acting against protozoa\n2.4.1. Triazinetrione derivative\n>TABLE>\n3. Agents acting on the nervous system\n3.1. Agents acting on the central nervous system\n3.1.1. Butyrophenone tranquillisers\n>TABLE>\n3.2. Agents acting on the autonomic nervous system\n3.2.1. Anti-adrenergics\n>TABLE>\n4. Anti-inflammatory agents\n4.1. Nonsteroidal anti-inflammatory agents\n4.1.1. Arylpropionic acid derivative\n>TABLE>\n4.1.2. Fenamate group derivatives\n>TABLE>\n5. Corticoides\n5.1. Glucocorticoides\n>TABLE>\nANNEX II\nLIST OF SUBSTANCES NOT SUBJECT TO MAXIMUM RESIDUE LIMITS\n1. Inorganic chemicals\n>TABLE>\n2. Organic compounds\n>TABLE>\n3. Substances generally recognised as safe\n>TABLE>\n4. Substances used in homeopathic veterinary medicinal products\n>TABLE>\n5. Substances used as food additives in foodstuffs for human consumption\n>TABLE>\n6. Substances of vegetable origin\n>TABLE>\nANNEX III\nLIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED\n1. Anti-infectious agents\n1.1. Chemotheurapeutics\n1.1.2. Benzenesulphonamides\n>TABLE>\n1.2. Antibiotics\n1.2.1. Beta-lactamase inhibitors\n>TABLE>\n1.2.2. Macrolides\n>TABLE>\n1.2.5. Aminoglycosides\n>TABLE>\n1.2.6. Quinolones\n>TABLE>\n1.2.9. Polymyxins\n>TABLE>\n1.2.10. Penicillins\n>TABLE>\n1.2.11. Florfenicol and related compounds\n>TABLE>\n2. Antiparasitic agents\n2.1. Agents acting against endoparasites\n2.1.2. Benzimidazoles and pro-benzimidazoles\n>TABLE>\n2.2. Agents acting against ectoparasites\n2.2.1. Formamidines\n>TABLE>\n2.2.2. Iminophenyl thiazolidine derivative\n>TABLE>\n2.2.3. Pyretrin and pyrethroids\n>TABLE>\n2.2.4. Organophosphates\n>TABLE>\n2.2.5. Acyl urea derivates\n>TABLE>\n2.3. Agents acting against endo- and ectoparasites\n2.3.1. Avermectins\n>TABLE>\n3. Agents acting on the nervous system\n3.2. Agents acting on the autonomic nervous system\n3.2.1. \u00e22 sympathomimetic agents\n>TABLE>\n5. Anti-inflammatory agents\n5.1. Nonsteroidal anti-inflammatory agents\n5.1.1. Arylpropionic acid derivative\n>TABLE>\n5.1.2. Enolic acid derivates\n>TABLE>\nANNEX IV\nLIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES FOR WHICH NO MAXIMUM LEVELS CAN BE FIXED\nPharmacologically active substance(s)\nAristolochia spp. and preparations thereof\nChloramphenicol\nChloroform\nChlorpromazine\nColchicine\nDapsone\nDimetridazole\nMetronidazole\nNitrofurans (including furazolidone)\nRonidazole"}